Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Gwendolyn Kerby

Concepts (146)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Tobacco Smoke Pollution
7
2023
227
0.920
Why?
Cystic Fibrosis
10
2018
1164
0.750
Why?
Respiratory Function Tests
8
2015
543
0.690
Why?
Smoking Cessation
4
2022
442
0.480
Why?
Pseudomonas Infections
2
2018
229
0.420
Why?
Spirometry
4
2012
234
0.400
Why?
Neuroendocrine Cells
1
2012
34
0.370
Why?
Cough
3
2013
123
0.360
Why?
Plethysmography
4
2012
104
0.280
Why?
Lung
4
2015
4122
0.260
Why?
Cotinine
3
2021
77
0.240
Why?
Lung Diseases, Interstitial
1
2012
677
0.230
Why?
Prednisone
2
2019
229
0.200
Why?
Sodium Chloride
2
2015
138
0.200
Why?
Child, Preschool
13
2022
11913
0.190
Why?
Pediatricians
1
2023
120
0.180
Why?
Dexamethasone
2
2019
368
0.180
Why?
Forced Expiratory Volume
4
2015
451
0.180
Why?
JNK Mitogen-Activated Protein Kinases
1
2002
153
0.180
Why?
Motivational Interviewing
1
2023
121
0.170
Why?
Child, Hospitalized
2
2020
52
0.170
Why?
Oscillometry
2
2011
35
0.170
Why?
Respiratory Physiological Phenomena
1
2021
34
0.160
Why?
Information Systems
1
2021
58
0.160
Why?
Hospitals, Pediatric
3
2019
561
0.160
Why?
Sample Size
1
2010
124
0.150
Why?
Electronic Health Records
2
2021
1210
0.150
Why?
Parents
4
2021
1394
0.140
Why?
Infant
11
2022
10114
0.140
Why?
Azithromycin
1
2018
101
0.130
Why?
Bronchoscopy
2
2016
227
0.120
Why?
Clinical Trials as Topic
2
2011
1064
0.110
Why?
Child
12
2023
22693
0.100
Why?
Macrophages
1
2002
1532
0.100
Why?
Environmental Exposure
1
2018
578
0.100
Why?
Pseudomonas aeruginosa
2
2018
392
0.100
Why?
Asthma
2
2019
1800
0.090
Why?
Hyperplasia
1
2012
164
0.090
Why?
Saline Solution, Hypertonic
1
2012
43
0.090
Why?
Male
16
2023
73396
0.090
Why?
Humans
21
2023
146342
0.080
Why?
Cross-Sectional Studies
2
2012
5899
0.080
Why?
Colorado
3
2020
4595
0.080
Why?
Patient Readmission
1
2016
778
0.080
Why?
Feasibility Studies
2
2011
1135
0.080
Why?
Smoking Prevention
2
2021
168
0.080
Why?
Practice Patterns, Physicians'
1
2019
1408
0.080
Why?
Anti-Bacterial Agents
2
2018
1942
0.080
Why?
Sensitivity and Specificity
2
2011
1998
0.070
Why?
Longitudinal Studies
3
2013
3017
0.070
Why?
Reproducibility of Results
3
2013
3416
0.070
Why?
Smoking
3
2021
1486
0.070
Why?
Female
14
2023
79499
0.070
Why?
Cystic Fibrosis Transmembrane Conductance Regulator
1
2011
373
0.070
Why?
Follow-Up Studies
3
2012
5439
0.060
Why?
Inpatients
2
2022
540
0.060
Why?
Administration, Inhalation
3
2018
567
0.060
Why?
Double-Blind Method
3
2018
2070
0.050
Why?
Case-Control Studies
1
2011
3647
0.050
Why?
Glucocorticoids
1
2008
536
0.050
Why?
Caregivers
2
2023
1080
0.050
Why?
Postoperative Complications
1
2016
3034
0.050
Why?
Adolescent
6
2022
22557
0.050
Why?
MAP Kinase Kinase 4
1
2002
24
0.050
Why?
Chromones
1
2002
43
0.050
Why?
Osmotic Pressure
1
2002
41
0.050
Why?
Mice, Inbred C3H
1
2002
252
0.040
Why?
Mitogen-Activated Protein Kinase Kinases
1
2002
126
0.040
Why?
Beclomethasone
1
2001
8
0.040
Why?
Flavonoids
1
2002
85
0.040
Why?
Morpholines
1
2002
130
0.040
Why?
Mitogen-Activated Protein Kinase 1
1
2002
170
0.040
Why?
Adrenal Glands
1
2001
77
0.040
Why?
p38 Mitogen-Activated Protein Kinases
1
2002
263
0.040
Why?
Mitogen-Activated Protein Kinases
1
2002
288
0.040
Why?
Drug Administration Schedule
2
2019
790
0.040
Why?
Recurrence
2
2018
1133
0.040
Why?
Single-Blind Method
1
2021
313
0.040
Why?
Cohort Studies
1
2011
6077
0.040
Why?
Interleukin-8
1
2001
268
0.040
Why?
MAP Kinase Signaling System
1
2002
307
0.040
Why?
Counseling
1
2023
406
0.040
Why?
Proto-Oncogene Proteins c-akt
1
2002
441
0.040
Why?
Tobacco Use
1
2020
67
0.040
Why?
Pulmonologists
1
2019
14
0.040
Why?
Vital Capacity
1
2010
293
0.040
Why?
Symptom Flare Up
1
2019
37
0.040
Why?
Cell Survival
1
2002
1105
0.040
Why?
Drug Substitution
1
2019
62
0.040
Why?
Proto-Oncogene Proteins
1
2002
616
0.040
Why?
Reference Values
1
2010
796
0.040
Why?
Enzyme Inhibitors
1
2002
823
0.040
Why?
Directive Counseling
1
2018
48
0.030
Why?
Inflammation Mediators
1
2001
508
0.030
Why?
Tobramycin
1
2018
63
0.030
Why?
Retrospective Studies
2
2016
17438
0.030
Why?
Anti-Inflammatory Agents
1
2001
474
0.030
Why?
Tumor Necrosis Factor-alpha
1
2002
1224
0.030
Why?
Consensus
1
2019
467
0.030
Why?
Family
1
2022
690
0.030
Why?
Pneumonia
1
2002
635
0.030
Why?
Treatment Outcome
4
2018
11821
0.030
Why?
Dimensional Measurement Accuracy
1
2015
11
0.030
Why?
Prospective Studies
4
2012
8123
0.030
Why?
Drug Therapy, Combination
1
2018
1036
0.030
Why?
Pediatrics
1
2023
1124
0.030
Why?
Cells, Cultured
1
2002
4118
0.030
Why?
Self Report
1
2019
870
0.030
Why?
Hospitalists
1
2019
288
0.030
Why?
Statistics, Nonparametric
2
2008
426
0.030
Why?
Social Support
1
2018
646
0.030
Why?
Apoptosis
1
2002
2439
0.020
Why?
Functional Residual Capacity
1
2013
7
0.020
Why?
RNA, Messenger
1
2001
2791
0.020
Why?
Isotonic Solutions
1
2012
43
0.020
Why?
Emergency Service, Hospital
2
2019
2363
0.020
Why?
Young Adult
2
2020
14330
0.020
Why?
Radiography, Thoracic
1
2013
174
0.020
Why?
Adult
3
2020
41087
0.020
Why?
Age Factors
1
2019
3347
0.020
Why?
Severity of Illness Index
1
2019
2921
0.020
Why?
Body Height
1
2012
205
0.020
Why?
Clinical Competence
1
2019
1272
0.020
Why?
Infant, Newborn
1
2022
6460
0.020
Why?
United States
2
2021
16136
0.020
Why?
Staphylococcus aureus
1
2013
459
0.020
Why?
Staphylococcal Infections
1
2013
397
0.020
Why?
Hospitalization
1
2019
2475
0.020
Why?
Body Weight
1
2012
968
0.020
Why?
Aged, 80 and over
1
2010
8391
0.020
Why?
Time Factors
1
2018
7109
0.020
Why?
Chi-Square Distribution
1
2008
517
0.020
Why?
Middle Aged
2
2018
36619
0.020
Why?
Quality Improvement
1
2016
1354
0.020
Why?
Administration, Oral
1
2008
872
0.010
Why?
Mice
1
2002
18297
0.010
Why?
Airway Resistance
1
2001
38
0.010
Why?
Risk Factors
1
2016
10921
0.010
Why?
Nebulizers and Vaporizers
1
2001
63
0.010
Why?
Probability
1
2001
309
0.010
Why?
Aged
1
2010
26432
0.010
Why?
Animals
1
2002
38107
0.010
Why?
Bronchoalveolar Lavage Fluid
1
2001
642
0.010
Why?
Analysis of Variance
1
2001
1298
0.010
Why?
Dose-Response Relationship, Drug
1
2001
2022
0.010
Why?
Pilot Projects
1
2001
1888
0.010
Why?
Kerby's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)